Epilepsy and bipolar meds recalled after contamination with another drug is discovered
One lot of epilepsy and bipolar disorder tablets got recalled Friday after someone discovered a cross-contamination with a drug used in heart and blood pressure medication, according to the FDA-posted recall.
The epilepsy and bipolar medication is Lamotrigine 100mg. Lamotrigine is also sold under Lamictal brand names. The drug substance that isn’t supposed to be there is Enalapril Maleate. The Lamotrigine and the heart and blood pressure medication were manufactured by Taro Pharmaceutical Industries out of Haifa Bay, Israel and distributed by Taro Pharmaceuticals USA, which made the recall.
This concerns lot No. 331771, expiration date June 2021, sold in 100-count bottles.
Patients with this drug should stop using it and return it to the pharmacy. Pharmacies and distributors should stop selling it.
Consumers with questions can email TaroPVUS@taro.com or call Taro at 866-923-4914, Monday through Friday, 8 a.m. to 8 p.m., Eastern time.
Any adverse reactions to any medication should be reported to your doctor, then to the FDA by clicking here.
This story was originally published January 11, 2020 at 10:11 AM.
